(Total Views: 159)
Posted On: 06/07/2019 11:20:20 AM
Post# of 44074
$OZSC Ozop Surgical Corp Announces Progress on New Spine Implant
Designed and Engineered to Speed Surgery and Provide Patient Optimized Fit
WEST PALM BEACH, FL / ACCESSWIRE / June 3, 2019 / Ozop Surgical Corp. (OTCQB:
OZSC), a provider of premium surgical devices in the rapidly growing field of
minimally invasive spine surgery, today announced significant development
progress and completion of initial testing of their novel adjustable ALIF
interbody spinal implant.
Michael Chermak, CEO, OZOP Surgical commented, "We are excited to have
completed initial testing for this novel device. Only through testing can we
learn how to create an optimal design and develop the instrumentation to allow
for an exceptional operative outcome for the surgeon and patient. Developing
an infinitely adjustable ALIF implant is a challenging design goal but the end
outcome will allow the surgeon to ensure segmental stability and restore
sagittal balance. We are encouraged by the results of this testing and have
incorporated several improvements into our next design. We look forward to
completing testing for FDA submission in the near future and hope to have our
approval by the end of the year".
About the OZOP Adjustable ALIF Implant
OZOP is developing an exciting new anterior spine implant that allows the
surgeon to expand it after insertion into the disc space. This allows for
patient specific adjustment, reduced operating time and inventory and cost
savings for the hospital. Instrumentation has been simplified and the locking
mechanism eliminates the cost and time needed for anterior supplemental
fixation.
About Ozop Surgical Corp.
Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops,
manufactures and distributes innovative endoscopic instruments, surgical
implants, instrumentation, devices and related technologies, focused on spine,
neurological and pain management procedures and specialties. Our focus is on
economically disrupting the market with clinically equivalent or superior
existing and new products resulting in immediate and significant savings for
providers, payors and consumers. For more information please visit
www.ozopsurgical.com.
Designed and Engineered to Speed Surgery and Provide Patient Optimized Fit
WEST PALM BEACH, FL / ACCESSWIRE / June 3, 2019 / Ozop Surgical Corp. (OTCQB:
OZSC), a provider of premium surgical devices in the rapidly growing field of
minimally invasive spine surgery, today announced significant development
progress and completion of initial testing of their novel adjustable ALIF
interbody spinal implant.
Michael Chermak, CEO, OZOP Surgical commented, "We are excited to have
completed initial testing for this novel device. Only through testing can we
learn how to create an optimal design and develop the instrumentation to allow
for an exceptional operative outcome for the surgeon and patient. Developing
an infinitely adjustable ALIF implant is a challenging design goal but the end
outcome will allow the surgeon to ensure segmental stability and restore
sagittal balance. We are encouraged by the results of this testing and have
incorporated several improvements into our next design. We look forward to
completing testing for FDA submission in the near future and hope to have our
approval by the end of the year".
About the OZOP Adjustable ALIF Implant
OZOP is developing an exciting new anterior spine implant that allows the
surgeon to expand it after insertion into the disc space. This allows for
patient specific adjustment, reduced operating time and inventory and cost
savings for the hospital. Instrumentation has been simplified and the locking
mechanism eliminates the cost and time needed for anterior supplemental
fixation.
About Ozop Surgical Corp.
Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops,
manufactures and distributes innovative endoscopic instruments, surgical
implants, instrumentation, devices and related technologies, focused on spine,
neurological and pain management procedures and specialties. Our focus is on
economically disrupting the market with clinically equivalent or superior
existing and new products resulting in immediate and significant savings for
providers, payors and consumers. For more information please visit
www.ozopsurgical.com.
(0)
(0)
